International Marketing Head - Formulations

Senior leadership role - Mumbai - Reports to the CEO - Indian & global markets

Location: Mumbai, India (with international travel)

Reports to CEO, with direct visibility to the Board of Directors

Qualification: B.Pharm + M.Pharm + MBA

Experience: 15+ years in international pharmaceutical formulations marketing / business development, with out-licensing and P&L ownership

Markets: Regulated (USA, EU, UK, Japan, Canada, Australia), emerging (Brazil, Russia, China, Korea, LATAM, RoW) and India

ABOUT US

Swati Spentose Pvt. Ltd. is a leading specialist manufacturer of complex molecules, polysaccharides and Active Pharmaceutical Ingredients (APIs). We are part of a 50+ year-old group currently exporting to 70 countries.

Our facilities hold accreditations from several global regulators, including USFDA, EDQM, and the health authorities of Russia, China, Japan, Mexico, Brazil, the UK, Australia and Canada. We have recently commissioned a 150 crore fully digitised and automated finished dosage facility, built to meet global regulatory standards.

THE OPPORTUNITY

This is the senior-most commercial role in our formulations business. You will build the international finished dosage business from the ground up. Working directly with the CEO and the Board, you will own the finished dosage pipeline, set the international strategy, monetise our outlicensing dossiers for India and worldwide markets, and lead all international marketing and sales.

We are looking for someone who intends to stay and build. This platform is designed for the long term, and so is this role.

KEY RESPONSIBILITIES

Finished dosage pipeline & portfolio

- Pipeline ownership: Take full ownership and control of the finished dosage (formulations) pipeline, from product selection through development, filing, approval and launch, with external partners, CROs and CMOs.

- Portfolio strategy: Select products on both scientific and commercial logic, including the realities of entering a market as a later entrant, across oral solids, topicals, injectables and advanced delivery formats.

- Lifecycle and IP: Drive line extensions, new dosage forms and IP filing extensions that create real value, along with portfolio rationalisation.

- In-licensing and acquisitions: Scout and evaluate in-licensing and asset acquisition opportunities across under-development, filed and approved formulations.

International strategy & market expansion

- Business strategy: Define and execute the international marketing and business strategy, with an annual business plan and a 3-5 year roadmap approved by the CEO and Board.

- Market entry and pricing: Set market-entry sequencing, go-to-market models (own front-end, distributor, licensing or profit-share) and country-specific pricing frameworks.

- Market intelligence: Track pricing, demand, competitor activity, regulatory shifts and therapeutic trends, and use them to prioritise registrations and launches.

Out-licensing dossiers - India & worldwide

- Out-licensing ownership: Own the out-licensing strategy and income for dossiers - developed, under development and approved MAs - for the India market and international territories.

- Deal-making: Identify licensees, lead negotiations and independently close dossier licensing, License & Supply, technology transfer and profit-share agreements.

- Commercial structuring: Work fluently with CMO costing, CCPC and profit-sharing structures, so that every partner is paid fairly and the partnership grows.

- Dossier readiness: Work with Regulatory, IP and R&D on CTD/eCTD readiness, technical due diligence and smooth transfer to licensees.

Marketing & sales leadership

- Marketing and sales: Lead all international marketing and sales end to end: brand strategy, B2B and digital engagement, exhibitions and promotional material.

- Partner management: Appoint, manage and grow distributors, agents, CMO partners and institutional buyers, and drive projects through to successful execution.

- Revenue and compliance: Own revenue targets and demand forecasting with Finance, Supply Chain and Operations, within international regulatory and ethical promotion standards.

- Team building: Build and grow the international marketing, sales and BD team required to scale this platform over the long term.

HOW SUCCESS WILL BE MEASURED

- Pipeline: FD products selected, filed and approved vs. plan; on-time milestones with CROs and CMOs

- Strategy: International business plan and 3-5 year market roadmap approved within the first 6 months

- Out-licensing: Deals signed for India and worldwide; licensing income and milestone revenue

- Revenue: International formulations revenue and gross margin vs. budget; new markets and distributors activated

- Team: Key hires in place; team retention and capability growth

Targets for each measure will be agreed with the CEO at joining.

WHAT WE ARE LOOKING FOR

- 15+ years in international pharmaceutical marketing and business development, including at least 5 years leading a finished dosage formulations business.

- A proven out-licensing track record. You have independently closed dossier out-licensing, license & supply or profit-share deals in India and international markets.

- Deep technical grounding in pharmaceuticals, particularly dossiers (CTD/eCTD), regulatory documentation and regulated-market requirements.

- Commercial leadership. P&L ownership, revenue delivery, and an established network of licensees, distributors and CMOs.

- Excellent written and spoken English, with the ability to draft high-quality correspondence and present clearly to a Board.

- A collaborative operator and developer of talent. You care more about the result than about who gets credit, and you bring capable people up to your own level.

- Commitment to the long term. We are building depth and expertise, and want someone who wants to build something significant here over many years.

WHAT WE OFFER

- A senior leadership mandate reporting directly to the CEO, with Board visibility and real autonomy to shape our global formulations business.

- A platform to build on: a new 150 crore finished dosage facility and a 50+ year API heritage.

- Competitive executive compensation with performance-linked incentives